Mental EnergyNCT07256665
The Cracking Consciousness Study With Monroe & Neuphoria
A study testing Neuphoria Wearable in people with Mental Energy and Stress, run by Efforia, Inc at 1 site in United States.
Trial summary
You've explored the Monroe Focus levels. But, Bob Monroe said, "You might believe something, but you won't understand it until you can measure it with objective data." Now, for the first time, we can measure them. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Mental Energy, Stress
- What is being tested?
- Neuphoria Wearable
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 271 participants
- Where
- 1 siteUnited States
- Study dates
- 10 Aug 2025to 10 Jan 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Can read and understand English.
- US resident.
- Willing and able to follow the requirements of the protocol.
Who cannot join
None listed.
Trial locations and contacts
1 site in 1 country.
About this study
You've explored the Monroe Focus levels. But, Bob Monroe said, "You might believe something, but you won't understand it until you can measure it with objective data." Now, for the first time, we can measure them. In partnership with Neuphoria, we're launching a groundbreaking EEG study to define Higher States of Consciousness. Join the World's First higher states of Consciousness Study.
Read the detailed description
This remotely administered decentralized trial is designed to explore the potential of the Neuphoria device, a cutting-edge wearable neurofeedback headset, in enhancing cognitive performance and facilitating the attainment of peak mental states. By leveraging advanced EEG technology to monitor brainwave activity in real-time, this study aims to provide participants with personalized feedback, assisting them in training their brains to improve focus, creativity, and achieve flow states. The device serves as a comprehensive brain optimization platform, offering personalized assessments, data-driven insights, and actionable recommendations for mental well-being.
In an era where mindfulness and meditation are highly valued, yet often unquantified, this study emerges as a pioneering effort to measure these elusive higher states of consciousness scientifically. In collaboration with Neuphoria, this trial endeavors to blend the art of introspection with the precision of EEG technology, thereby transforming belief into understanding and folklore into facts. The ultimate goal is to redefine mental wellness by gaining a deeper understanding of consciousness shifts.
Participants in this trial are invited to embark on a unique journey of self-discovery, exploring their mental landscapes while capturing data that reflects their progress toward higher consciousness. Through engagement with meditation and mindfulness techniques, participants will not only gain insights into their stress levels and mindfulness tendencies, quantified through tools like the Perceived Stress Scale and the Freiburg Mindfulness Inventory, but also discover their personal pathways to enhanced mental wellness and consciousness.
The study's primary aim is to objectively measure shifts in participants' consciousness using EEG data, in conjunction with traditional mindfulness and stress metrics. By offering personalized insights into the effects of meditation and mindfulness on mental health, the study empowers participants to make informed decisions regarding their self-care practices.
The significance of this trial lies in its potential to transform subjective meditation experiences into objective, measurable data, thereby narrowing the gap between belief and measurable outcomes. Understanding the influence of mindfulness practices on consciousness could significantly advance mental health optimization strategies. While acknowledging the limitations in the universal applicability of its results, the personalized insights provided by this study promise to be invaluable for participants eager to deepen their mindfulness practice and achieve a state of equanimity. Through this innovative, remotely administered trial, we aim to illuminate the path to mental wellness and elevated consciousness for individuals across the globe.
- Conditions
- Mental Energy, Stress
- Being tested
- Neuphoria Wearable
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Neuphoria WearableDevice
Neuphoria wearable measures Electroencephalography (EEG) brainwaves.
| Study group | Role | What they receive |
|---|---|---|
| Single Arm longitudinal where participants act as their own control | Experimental | Single Arm longitudinal where participants act as their own control Receives: Device: Neuphoria Wearable |
What is being measured
The primary outcome is the main question the study is designed to answer.
Neuphoria Brain EEG
Neuphoria's wearable neurofeedback system harnesses real-time EEG to generate a rich, multidimensional cognitive profile by measuring five core metrics-mental state, mindset, nervous system activity, emotion, and breathing patterns-all displayed via its biohacking dashboard to offer users nuanced insights into their cognitive and physiological functioning
Measured: Change from baseline (Day 1-7) in cognitive and physiological profiles at 4 to 5 weeks (Day 23-37) after the start of the intervention
Perceived Stress Scale (Past Week Version)
The Perceived Stress Scale (Past Week Version) is a modified version of the classic stress assessment tool that evaluates stress levels based on recent experiences within the last week. This scale helps in understanding how various situations have recently affected an individual's feelings and perceived stress levels. By focusing on a shorter time frame, it provides a more immediate assessment of stress, which can be particularly useful for quickly evaluating the effectiveness of stress management strategies or interventions. The tool retains its original structure, ensuring its reliability while making it more relevant for current stress evaluation.
Measured: Change from baseline (Day 1-3) in perceived stress levels at 4 to 5 weeks (Day 27-33) after the start of the intervention
Freiburg Mindfulness Inventory
The Freiburg Mindfulness Inventory (FMI) is a valid and reliable questionnaire designed to measure mindfulness. The 14 items in the inventory cover all aspects of mindfulness. Participants are asked to reflect on their experiences over a certain period of time and answer each statement as honestly and spontaneously as possible. There are no 'right' or 'wrong' answers, the focus is solely on personal experience.
Measured: Change from baseline (Day 1-3) in mindfulness levels at 4 to 5 weeks (Day 27-33) after the start of the intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Dec 2025
- Study start10 Aug 2025
- Primary completion10 Jan 2026
- Study completion10 Jan 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Mental EnergyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- Single Arm observational where participants act as their own control
- Masking
- None (open label)
- Enrolment
- 271 participants (actual)
Sponsor and investigators
- Lead sponsor
- Efforia, Inc
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07256665
- Sponsor's protocol ID
- 41035
- Status last verified
- May 2026
- First submitted
- 20 Nov 2025
- Last updated
- 28 May 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 28 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Cracking Consciousness Study With Monroe & Neuphoria
- ClinicalTrials.gov ID
- NCT07256665
- Acronym / sponsor ID
- 41035
- Conditions
- Mental Energy, Stress
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 271 participants (actual)
- Lead sponsor
- Efforia, IncIndustry (pharma, biotech, devices)
- Study start
- 10 Aug 2025 (actual)
- Primary completion
- 10 Jan 2026 (actual)
- Study completion
- 10 Jan 2026 (actual)
- First posted
- 1 Dec 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
You've explored the Monroe Focus levels. But, Bob Monroe said, "You might believe something, but you won't understand it until you can measure it with objective data." Now, for the first time, we can measure them. In partnership with Neuphoria, we're launching a groundbreaking EEG study to define Higher States of Consciousness. Join the World's First higher states of Consciousness Study.
Detailed description
This remotely administered decentralized trial is designed to explore the potential of the Neuphoria device, a cutting-edge wearable neurofeedback headset, in enhancing cognitive performance and facilitating the attainment of peak mental states. By leveraging advanced EEG technology to monitor brainwave activity in real-time, this study aims to provide participants with personalized feedback, assisting them in training their brains to improve focus, creativity, and achieve flow states. The device serves as a comprehensive brain optimization platform, offering personalized assessments, data-driven insights, and actionable recommendations for mental well-being.
In an era where mindfulness and meditation are highly valued, yet often unquantified, this study emerges as a pioneering effort to measure these elusive higher states of consciousness scientifically. In collaboration with Neuphoria, this trial endeavors to blend the art of introspection with the precision of EEG technology, thereby transforming belief into understanding and folklore into facts. The ultimate goal is to redefine mental wellness by gaining a deeper understanding of consciousness shifts.
Participants in this trial are invited to embark on a unique journey of self-discovery, exploring their mental landscapes while capturing data that reflects their progress toward higher consciousness. Through engagement with meditation and mindfulness techniques, participants will not only gain insights into their stress levels and mindfulness tendencies, quantified through tools like the Perceived Stress Scale and the Freiburg Mindfulness Inventory, but also discover their personal pathways to enhanced mental wellness and consciousness.
The study's primary aim is to objectively measure shifts in participants' consciousness using EEG data, in conjunction with traditional mindfulness and stress metrics. By offering personalized insights into the effects of meditation and mindfulness on mental health, the study empowers participants to make informed decisions regarding their self-care practices.
The significance of this trial lies in its potential to transform subjective meditation experiences into objective, measurable data, thereby narrowing the gap between belief and measurable outcomes. Understanding the influence of mindfulness practices on consciousness could significantly advance mental health optimization strategies. While acknowledging the limitations in the universal applicability of its results, the personalized insights provided by this study promise to be invaluable for participants eager to deepen their mindfulness practice and achieve a state of equanimity. Through this innovative, remotely administered trial, we aim to illuminate the path to mental wellness and elevated consciousness for individuals across the globe.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- Single Arm observational where participants act as their own control
| Arm | Type | Receives |
|---|---|---|
| Single Arm longitudinal where participants act as their own control | Experimental | Device: Neuphoria WearableSingle Arm longitudinal where participants act as their own control |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Can read and understand English.
- US resident.
- Willing and able to follow the requirements of the protocol.
Key exclusion criteria (0 listed)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Neuphoria WearableNeuphoria wearable measures Electroencephalography (EEG) brainwaves. | Device | Single Arm longitudinal where participants act as their own control |
Primary outcome
Neuphoria Brain EEG
Time frame: Change from baseline (Day 1-7) in cognitive and physiological profiles at 4 to 5 weeks (Day 23-37) after the start of the intervention
Neuphoria's wearable neurofeedback system harnesses real-time EEG to generate a rich, multidimensional cognitive profile by measuring five core metrics-mental state, mindset, nervous system activity, emotion, and breathing patterns-all displayed via its biohacking dashboard to offer users nuanced insights into their cognitive and physiological functioning
Perceived Stress Scale (Past Week Version)
Time frame: Change from baseline (Day 1-3) in perceived stress levels at 4 to 5 weeks (Day 27-33) after the start of the intervention
The Perceived Stress Scale (Past Week Version) is a modified version of the classic stress assessment tool that evaluates stress levels based on recent experiences within the last week. This scale helps in understanding how various situations have recently affected an individual's feelings and perceived stress levels. By focusing on a shorter time frame, it provides a more immediate assessment of stress, which can be particularly useful for quickly evaluating the effectiveness of stress management strategies or interventions. The tool retains its original structure, ensuring its reliability while making it more relevant for current stress evaluation.
Freiburg Mindfulness Inventory
Time frame: Change from baseline (Day 1-3) in mindfulness levels at 4 to 5 weeks (Day 27-33) after the start of the intervention
The Freiburg Mindfulness Inventory (FMI) is a valid and reliable questionnaire designed to measure mindfulness. The 14 items in the inventory cover all aspects of mindfulness. Participants are asked to reflect on their experiences over a certain period of time and answer each statement as honestly and spontaneously as possible. There are no 'right' or 'wrong' answers, the focus is solely on personal experience.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 May 2026.
- Additional information and join instructions on EfforiaLink provided by the sponsor.
Related trials for Mental Energy
Recruiting
A Clinical Trial to Evaluate the Effects of Adrenal Adapt on Sleep Quality, Daytime Energy, Stress Resilience, and Cognitive Performance.
Improves Daytime Energy Levels, Reduces Afternoon Energy Crashes and Midday Fatigue
RecruitingObservational study
The ATP Project (Antipsychotic-TEP-Psychosis)
First Episose Psychosis, Metabolic Disease
Active, not recruiting
A Study to Evaluate the Effects of a Beef Liver Supplement on Energy, Mood, and Mental Clarity
Fatigue, Low Mood
Not yet recruiting
Time-Restricted Eating and Personalized Energy-Restricted Diet in Obese Postmenopausal Women
Obesity (BMI Equal to or >30), Postmenopausal Symptoms
Active, not recruiting
Effects of a Multi-Targeted Oral Supplement on Skin, Hair, Sleep, Energy, Cognition, Libido and Epigenetic Biological Clock Age
Skin Ageing, Healthy Ageing
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Neuphoria Wearable in people with Mental Energy and Stress, run by Efforia, Inc at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Neuphoria Brain EEG (time frame: Change from baseline (Day 1-7) in cognitive and physiological profiles at 4 to 5 weeks (Day 23-37) after the start of the intervention). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 May 2026.